Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The 13-amino-acid N-terminal extension adds steric interference
Data from longer-term treatment will therefore be eagerly awaited to determine the extent of body weight loss and metabolic outcomes and whether this is comparable to the latest GLP-1 mono-agonist therapies
The one primary-source injectable number comes from a 1990s ProCyte hair-growth patent, which describes intradermal formulations of the AHK-Cu class at 100500 micrograms per 0.1 mL in saline or sterile water [4] but that is an animal / formulation specification, not a human dose
GLP-1 receptor agonists act on the pancreas by enhancing insulin secretion, inhibiting glucagon release (see #4 below), and there is some evidence to suggest that they protect the beta cells from damage
Semaglutide GLP-1, a medication increasingly being used in the weight management field, is one of the options our healthcare professionals may recommend
